Piramal Pharma Ltd

NSE : PPLPHARMA14 Feb 2025
Pharmaceuticals
-15.66 (-7.81%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Piramal Pharma Ltd
Piramal Pharma Ltd
Pharmaceuticals
NSE : PPLPHARMA14 Feb 2025
-15.66 (-7.81%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Piramal Pharma Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
35.91%
Upper Circuit
Lower Circuit
P/E TTM
35.68
P/B Ratio
3.49
Traded Value(Cr)
0.00
EPS TTM
5.18
Book value
Dividend
0.06%

Invest in Piramal Pharma Ltd at ZERO Brokerage for 30 days

Price Performance

-18.35 %
1 Wk
-21.30 %
1 M
-28.46 %
3 M
35.91 %
1 Y
-28.40 %
YTD

Traded Volume Movement

Technical Details

Support 3
158
Support 2
170
Support 1
178
Pivot Point :
190
Resistance 1
198
Resistance 2
210
Resistance 3
218

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Piramal Pharma Ltd
₹184.90(-15.66/-7.81%)
184.90-15.6624,513.0835.9135.683.49
Ipca Laboratories Ltd
₹1,463.90(-27.00/-1.81%)
1,463.90-27.0037,139.7626.7853.165.50
Lupin Ltd
₹1,969.90(-85.35/-4.15%)
1,969.90-85.3589,922.1922.2228.734.09
J B Chemicals & Pharmaceuticals Ltd
₹1,669.30(-14.40/-0.86%)
1,669.30-14.4025,975.36-0.4041.258.21
IOL Chemicals & Pharmaceuticals Ltd
₹336.40(-15.15/-4.31%)
336.40-15.151,974.85-17.3120.301.19
Sanofi India Ltd
₹5,149.75(-225.45/-4.19%)
5,149.75-225.4511,859.87-42.2328.2217.38

About Piramal Pharma Ltd

Piramal Pharma Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 24499.83 crores. It has reported a sales of Rs. 1248.32 crores and a net profit of Rs. 118.8 crores for the quarter ended December 2018. The company management includes Nandini Piramal, Nandini Piramal,PETER D DEYOUNG,Neeraj Bharadwaj,Jairaj Purandare,S Rama Dorai,Peter Stevenson,Sridhar Gorthi,Vibha Paul Rishi,Vivek Valsaraj,Tanya D'Costa,Nathalie Leitch (Piramal Pharma Ltd) among others.
Chairman
Nandini Piramal
Registered office
Ground Floor Piramal Ananta,Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra,400070
FAX :91-22-3802 3884
Background
Incorporation Year2020
Face Value₹10
Market Lot1

Latest News

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Trump, Tariffs & Trades: Sensex ends in red for 8th straight day

India's equity indices fell for the eighth straight day, the longest losing streak in two years, due to concerns over Donald Trump's trade tariff proposals, with Nifty and Sensex declining 0.44% and 0.26% respectively. Analysts believe the market is oversold and a bounce back may depend on a slowdown in foreign fund selling.
15 Feb 2025 | 10:55 AM

Easy Trip Planners Q3 Profit Drops 26%, Hotel Bookings Surge 172%

Easy Trip Planners Ltd (ETPL) reported a 26.3% year-on-year decline in net profit to ₹33.6 crore for Q3 FY25, with revenue from operations down 6.5% to ₹150.5 crore. EBITDA fell 21.8% to ₹47.7 crore, with a 31.7% margin. Despite this, gross booking revenue for 9M FY25 was ₹6,499 crore, driven by strong growth in hotel and other bookings.
15 Feb 2025 | 04:26 PM

Glenmark Pharmaceuticals Q3 results 2025 on 15 Feb, 2025

Glenmark Pharmaceuticals Q3 Results 2025: Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a significant increase in topline by 35.14%, with profit reaching ₹347.96 Cr. This marks a remarkable turnaround from the loss of ₹351.37 Cr reported during the same period in the previous fiscal year.
15 Feb 2025 | 02:09 PM

Sakuma Exports Q3 Results 2025 on 15 Feb, 2025

Q3 Results 2025: Sakuma Exports declared their Q3 results on 14 Feb, 2025, revealing a significant decline in financial performance. The company’s topline decreased by 38.68% year-over-year (YoY), with profit plummeting by 47.75% YoY. For Q3, Sakuma reported a profit of ₹3.37 crore and revenue of ₹477.73 crore.
15 Feb 2025 | 02:06 PM

How to buy Piramal Pharma Ltd shares on nse?

To buy Piramal Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Piramal Pharma Ltd share price today?

The Piramal Pharma Ltd shares price on nse is Rs.184.9 today.

What is the market cap of Piramal Pharma Ltd shares on NSE ?

The company has a market capitalization of Rs.24513.08Cr

What is the PE & PB ratio of Piramal Pharma Ltd shares ?

PE is 35.68 and PB is 3.49

What is the 52 Week High and Low of Piramal Pharma Ltd shares?

Piramal Pharma Ltd stock price high: Rs.307.9 Piramal Pharma Ltd stock price low: Rs.114.35

What can be the future price of Piramal Pharma shares on BSE?

The current price of Piramal Pharma on BSE is 71.51 (24 March 2023, 3:25 PM).

The future price of any shares on BSE, including those of Piramal shares are based on a variety of factors and these may lead to changes in the price of a stock at any time. The following factors must be considered while thinking of the future price of Piramal Pharma stocks: 

  • The position of the company in the pharmaceutical industry
  • Innovations of the company
  • Financial and overall company performance
  • Macroeconomic factors
  • Demand for pharmaceuticals
  • Competition

Is it safe to buy Piramal Pharma?

Piramal Pharma, a pharmaceutical company and part of the erstwhile Piramal Group, is a global business with a focus on providing innovative/integrated solutions across the total drug development and manufacturing value chain, right from drug discovery to the commercialisation of medicines. 

Whether a stock is safe to buy or not should be based on many factors like the financials of the company, the competition, the position of the company in the industry, macroeconomic factors and more. 

Nonetheless, the net sales of Piramal Pharma were at Rs. 6559 crores in March 2022, and the net profit was at Rs. 376 crores.

 

What is the current market value per shares of Piramal Pharma?

The current price of Piramal Pharma on BSE is 71.51 (24 April 2023, 3:25 PM).

Does Piramal Pharma have any debts?

As of 24 April 2023, Piramal Pharma has debt amounting to Rs. 5016 crores. 

Will Piramal Pharma shares price increase?

The ROI on Piramal Pharma stock is -65.32% (YTD). 

Determining whether share prices will increase depends on many factors like macroeconomic factors, the company’s performance, trends in the industry, the competition and other variables that influence stock prices frequently, besides on a long-term basis.

 

Should I buy or sell Piramal Pharma?

The 3-month returns on investment (ROI) of Piramal Pharma stock is -35.62%, and YTD is at -65.32%. 

Given this data, any stock’s movement depends on several factors which include: 

  • Company performance
  • Industry trends
  • Market trends
  • Competition
  • Demand and supply
  • Macroeconomic trends